Cargando…
The Omicron COVID‐19 threat to dialysis patients is dramatically lower than previous variants
Autores principales: | Al Madani, Ayman Kamal, Al Obaidli, Ali Kareem, Ahmed, Wasim, AlKaabi, Nawal Ahmed, Holt, Stephen Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348243/ https://www.ncbi.nlm.nih.gov/pubmed/35641846 http://dx.doi.org/10.1111/nep.14065 |
Ejemplares similares
-
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates
por: Holt, Stephen Geoffrey, et al.
Publicado: (2021) -
Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody
por: Ahmed, Wasim, et al.
Publicado: (2021) -
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
por: Altarawneh, Heba N., et al.
Publicado: (2022) -
Predicting hypertension using machine learning: Findings from Qatar Biobank Study
por: AlKaabi, Latifa A., et al.
Publicado: (2020) -
Risks for bicycle-related injuries in Al Ain city, United Arab Emirates: An observational study
por: Grivna, Michal, et al.
Publicado: (2021)